Old Web
English
Sign In
Acemap
>
authorDetail
>
Fenqing Chi
Fenqing Chi
Shanxi Medical University
Internal medicine
Medicine
Cancer
Proportional hazards model
Survival analysis
4
Papers
4
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Dasatinib inhibits proliferation of liver cancer cells, but activation of Akt/mTOR compromises dasatinib as a cancer drug.
2021
Acta Biochimica et Biophysica Sinica
Chang Liu
Xiaoxia Zhu
Yuqi Jia
Fenqing Chi
Keru Qin
Jinhong Pei
Chan Zhang
Xiuli Mu
Hongwei Zhang
Xiushan Dong
Jun Xu
Baofeng Yu
Show All
Source
Cite
Save
Citations (0)
Chidamide induces apoptosis in DLBCL cells by suppressing the HDACs/STAT3/Bcl‑2 pathway
2021
Molecular Medicine Reports
Hong-wei Zhang
Fenqing Chi
Keru Qin
Xiuli Mu
Lieyang. Wang
Bin Yang
Yanli Wang
Min Bai
Zhenhua Li
Liping Su
Baofeng Yu
Show All
Source
Cite
Save
Citations (3)
Higher postoperative plasma EV PD-L1 predicts poor survival in patients with gastric cancer.
2021
Journal for ImmunoTherapy of Cancer
Gaopeng Li
Guoliang Wang
Fenqing Chi
Yuqi Jia
Xi Wang
Quankai Mu
Keru Qin
Xiaoxia Zhu
Jing Pang
Baixue Xu
Guangen Feng
Yuhu Niu
Gong Tao
Hongwei Zhang
Xiushan Dong
Ting Liu
Jinfeng Ma
Zefeng Gao
Kai Tao
Feng li
Jun Xu
Baofeng Yu
Show All
Source
Cite
Save
Citations (1)
Higher Post-Operative Plasma EV PD-L1 Predicts Poor Survival in Gastric Cancer Patients
2020
Gaopeng Li
Guoliang Wang
Fenqing Chi
Yuqi Jia
Xi Wang
Keru Qin
Xiaoxia Zhu
Jing Pang
Baixue Xu
Guangen Feng
Yuhu Niu
Gong Tao
Hongwei Zhang
Xiushan Dong
Ting Liu
Jinfeng Ma
Zefeng Gao
Kai Tao
Feng li
Baofeng Yu
Jun Xu
Show All
Source
Cite
Save
Citations (0)
1